TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
CXADRP1 |
|
CXADR pseudogene 1
|
|
|
0.463 |
0.846 |
ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
HRX |
|
Hyperreflexia
|
|
|
0.695 |
0.192 |
DDX39A |
O00148
|
DExD-box helicase 39A
|
|
0.60 |
0.674 |
0.692 |
HAX1 |
O00165
|
HCLS1 associated protein X-1
|
|
8.5E-08 |
0.631 |
0.577 |
PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
BIN1 |
O00499
|
bridging integrator 1
|
|
0.78 |
0.550 |
0.692 |
CCN1 |
O00622
|
cellular communication network factor 1
|
Signaling
|
0.71 |
0.473 |
0.731 |
PSMA7 |
O14818
|
proteasome 20S subunit alpha 7
|
|
0.99 |
0.659 |
0.462 |
KDM6B |
O15054
|
lysine demethylase 6B
|
Epigenetic regulator
|
1.00 |
0.514 |
0.808 |
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
AP5Z1 |
O43299
|
adaptor related protein complex 5 subunit zeta 1
|
|
7.3E-31 |
0.700 |
0.346 |
ZEB2 |
O60315
|
zinc finger E-box binding homeobox 2
|
Transcription factor
|
1.00 |
0.471 |
0.808 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
TRIM13 |
O60858
|
tripartite motif containing 13
|
|
0.64 |
0.462 |
0.846 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
ATG7 |
O95352
|
autophagy related 7
|
Enzyme
|
7.4E-12 |
0.505 |
0.769 |
GSR |
P00390
|
glutathione-disulfide reductase
|
Enzyme
|
1.3E-06 |
0.494 |
0.846 |
HPRT1 |
P00492
|
hypoxanthine phosphoribosyltransferase 1
|
Enzyme
|
0.94 |
0.500 |
0.808 |
ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
F2 |
P00734
|
coagulation factor II, thrombin
|
Enzyme
|
1.1E-03 |
0.415 |
0.885 |
F9 |
P00740
|
coagulation factor IX
|
Enzyme
|
1.00 |
0.465 |
0.885 |